Co-op: Chemistry Analytical Development
Posted on: 18 Jan 2021
Research Triangle Park, NC
Job Description
Job Description
The Co-Op position will be in the Analytical Development group at Biogen, which is responsible for evaluation and implementation of new analytical technology and methods. This position will systematically evaluate new electrophoretic instrumentation to support our Pioneering goals and increase the Agility of Analytical Development by introducing new technology for routine use.
Position Description
We are seeking a highly motivated co-op student to work as a member of the Chemistry Analytical Development group at Biogen in RTP, NC. The candidate will explore new technologies and instrumentation, as well as assist in method optimization. Specifically, this candidate will focus on introducing and implementing a new analytical instrumentation for protein characterization. This will involve working closely with analytical chemist to evaluate and potentially qualify methods on the new instrumentation platform.
Qualifications
To participate in the Biogen Internship Program, students must meet the following eligibility criteria:
* Legal authorization to work in the U.S.
* Grade point average of 3.2 or higher preferred
* At least 18 years of age prior to the scheduled start date
* Be currently enrolled in an accredited college or university
Additional qualifications
This position requires a high level of self-motivation, excellent communication skills, ability to work independently and the ability to handle multiple tasks. Preferred candidates will have a good understanding of basic analytical chemistry fundamentals and be able to bring in new assay innovations and/or implement existing assays in various environments. Additional requirements include accurate record keeping, data analysis using various software packages, and ability to follow standard operation procedures.
Education
Enrolled in a B.S. degree in Chemistry, Biochemistry, or Biological Sciences.
Additional Information
All your information will be kept confidential according to EEO guidelines.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
